Literature DB >> 34907499

Call on the reserve: Coronary vasomotor dysfunction is a potential biomarker of cardiovascular risk in patients with breast cancer.

Michael T Osborne1, Simran Grewal2, Tomas G Neilan2.   

Abstract

Entities:  

Year:  2021        PMID: 34907499      PMCID: PMC9192821          DOI: 10.1007/s12350-021-02831-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


× No keyword cloud information.
  20 in total

1.  Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Authors:  Saro H Armenian; Christina Lacchetti; Daniel Lenihan
Journal:  J Oncol Pract       Date:  2016-12-06       Impact factor: 3.840

2.  Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

Authors:  Navkaranbir S Bajaj; Michael T Osborne; Ankur Gupta; Ali Tavakkoli; Paco E Bravo; Tomas Vita; Courtney F Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Deepak L Bhatt; Marcelo F Di Carli; Viviany R Taqueti
Journal:  J Am Coll Cardiol       Date:  2018-08-14       Impact factor: 24.094

3.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

4.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Karol E Watson; Ana Barac; Theresa M Beckie; Vera Bittner; Salvador Cruz-Flores; Susan Dent; Lavanya Kondapalli; Bonnie Ky; Tochukwu Okwuosa; Ileana L Piña; Annabelle Santos Volgman
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

5.  Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.

Authors:  Lee W Jones; Kerry S Courneya; John R Mackey; Hyman B Muss; Edith N Pituskin; Jessica M Scott; Whitney E Hornsby; April D Coan; James E Herndon; Pamela S Douglas; Mark Haykowsky
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

6.  Detrimental effects of chemotherapy on human coronary microvascular function.

Authors:  Shelby N Hader; Natalya Zinkevich; Laura E Norwood Toro; Alison J Kriegel; Amanda Kong; Julie K Freed; David D Gutterman; Andreas M Beyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

7.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

Review 8.  Cardiorespiratory fitness in breast cancer patients: a call for normative values.

Authors:  Amanda B Peel; Samantha M Thomas; Kim Dittus; Lee W Jones; Susan G Lakoski
Journal:  J Am Heart Assoc       Date:  2014-01-13       Impact factor: 5.501

9.  Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy.

Authors:  Heather R Banister; Stephen T Hammond; Shannon K Parr; Shelbi L Sutterfield; Vanessa-Rose G Turpin; Scott Treinen; Martin J Bell; Carl J Ade
Journal:  Cardiooncology       Date:  2021-05-13

10.  Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation.

Authors:  John D Groarke; Sanjay Divakaran; Anju Nohria; Joseph H Killoran; Sharmila Dorbala; Ruth M Dunne; Jon Hainer; Viviany R Taqueti; Ron Blankstein; Harvey J Mamon; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2020-07-20       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.